Current insight into the regulation of PD-L1 in cancer

Exp Hematol Oncol. 2022 Jul 30;11(1):44. doi: 10.1186/s40164-022-00297-8.

Abstract

The molecular mechanisms underlying cancer immune escape are a core topic in cancer immunology research. Cancer cells can escape T cell-mediated cellular cytotoxicity by exploiting the inhibitory programmed cell-death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1, CD274) immune checkpoint. Studying the PD-L1 regulatory pattern of tumor cells will help elucidate the molecular mechanisms of tumor immune evasion and improve cancer treatment. Recent studies have found that tumor cells regulate PD-L1 at the transcriptional, post-transcriptional, and post-translational levels and influence the anti-tumor immune response by regulating PD-L1. In this review, we focus on the regulation of PD-L1 in cancer cells and summarize the underlying mechanisms.

Keywords: Cancer; Cancer immunotherapy; Epigenetic regulation; PD-L1; Post-translational modification; Transcriptional regulation.

Publication types

  • Review